Geoff Mulvihill

Associated Press

In this Oct. 21, 2020, file photo Purdue Pharma headquarters stands in Stamford, Conn. Purdue Pharma pleaded guilty Tuesday, Nov. 24 to three criminal charges, formally admitting its role in an opioid epidemic that has contributed to hundreds of thousands of deaths over the past two decades.

OxyContin Maker Pleads Guilty in Criminal Case

Purdue Pharma admitted impeding the U.S. Drug Enforcement Administration's efforts to combat the addiction crisis.

A Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. A federal bankruptcy judge ruled Tuesday, July 28, 2020 that OxyContin maker Purdue Pharma can't make any more contributions to partisan organizations that seek to boost the election efforts of candidates for state attorney general offices.

Judge: Purdue Pharma Must Halt Some Political Contributions

Purdue contributed to attorneys general associations even while negotiating a settlement with states over the opioid crisis.

Christina Caldwell, left, of Henry Ford Population Health helps unload supplies with Matt Thatcher, who donated them from the Detroit Golf Club, Wednesday, April 8, 2020, in Detroit. The hospital is also in need of gowns and other PPE items and hopes more donations will be coming in from others to help during the coronavirus pandemic.

Creative Hunt for Supplies

The federal cupboard is officially bare.

In this July 1, 2013 file photo, is the exterior of the Mallinckrodt Pharmaceuticals office in St. Louis.

Generic Drugmakers Sold Most Opioids During Overdose Crisis

Court documents reveal a company culture that allowed Mallinckrodt to become one of the giants of the prescription opioid market.

I Stock 1162845770

Drugmaker Reaches $1.6B Opioid Settlement

The deal is intended to end hundreds of lawsuits faced by the company over opioids.

This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. OxyContin maker Purdue Pharma launched an ad campaign Monday, Feb. 24, 2020, to tell people harmed by their powerful prescription opioid where they can file claims against the company.

Purdue Pharma Starts Claim Campaign

It tells people where they can file claims against the company.

This June 17, 2019, file photo shows 5-mg pills of Oxycodone. The judge overseeing the bankruptcy case of OxyContin maker Purdue Pharma will consider Wednesday, Dec. 4, 2019 whether the company's CEO should get a bonus equal to half his $2.6 million salary.

Bankruptcy Judge Considers Purdue Pharma CEO's $1.3M Bonus

Purdue says maintaining its bonus program is essential to keep employees on the job and performing.

In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. OxyContin maker Purdue Pharma paid its CEO $9 million and its board chairman nearly $4 million in the 12 months before the company's bankruptcy filing last month, according to financial documents filed with the bankruptcy court this week.

Purdue Paid CEO $9M Before Bankruptcy

Five other board members overseeing the private company were paid a combined $3.7 million over that span.

Summit county executive Ilene Shapiro speaks to the media outside the U.S. Federal courthouse, Monday, Oct. 21, in Cleveland.

Companies Reach $260M Deal to Settle Opioids Lawsuit

The settlement ends only the suits brought by the Ohio counties of Cuyahoga and Summit.

In this Wednesday, Sept. 11, 2019, file photo, narcotics detective Ben Hill, with the Barberton Police Department, shows two bags of medications that are are stored in their headquarters and slated for destruction in Barberton, Ohio. Jury selection is set to begin Wednesday, Oct. 16, 2019, in the first federal trial over the nation's opioid epidemic.

Opioid Industry Presses for Settlement

The talks involve the distributors AmerisourceBergen, Cardinal Health and McKesson, as well as drug makers Johnson & Johnson and Teva.

In a Nov. 6, 2018 file photo, Dave Yost speaks at the Ohio Republican Party event, in Columbus, Ohio. A federal appeals court has denied an effort by state attorneys general to stop a bellwether opioids trial involving two Ohio counties from getting underway later this month in Cleveland. The Sixth Circuit U.S. Court of Appeals in Cincinnati ruled Thursday, Oct. 10, 2019 that Ohio didn’t object when lawsuits filed by Summit and Cuyahoga counties were initially included in what has become a sprawling case involving around 2,600 local governments and other entities. Yost argued in August against the certification of the local government lawsuits as multi-district litigation.

Court Denies Attempts to Stop Opioid Trial

The trial for Ohio's Summit and Cuyahoga counties is a closely watched bellwether that could lead to settlements of the suits.

In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday, Oct. 4, 2019 blasted the terms of OxyContin maker Purdue Pharma’s offer to settle thousands of lawsuits over the toll of the nation’s opioids crisis.

True Profits of OxyContin Revealed

Previously, former Purdue CEO Richard Sackler gave only a broad range — between $1 billion and $10 billion — that the family made from its signature painkiller.